GLIDAPA TENMET 1000

Description

GLIDAPA TENMET 1000 is an advanced triple-combination antidiabetic medication containing Dapagliflozin 10 mg, Teneligliptin 20 mg, and Metformin Hydrochloride 1000 mg (Extended Release). This combination is commonly prescribed for the effective management of Type 2 Diabetes, a chronic metabolic disorder characterized by elevated blood sugar levels due to insulin resistance or insufficient insulin production. Managing blood glucose levels is crucial because uncontrolled diabetes can lead to serious health complications such as Heart Disease, Kidney Disease, nerve damage, and vision problems. GLIDAPA TENMET 1000 combines three powerful antidiabetic agents that work through different mechanisms to help regulate blood sugar levels effectively. Dapagliflozin belongs to the SGLT2 inhibitor class of medicines, which help remove excess glucose from the body through urine. Teneligliptin is a DPP-4 inhibitor that improves insulin secretion and reduces glucose production in the liver. Metformin Hydrochloride (Extended Release) helps decrease glucose production in the liver and improves the body's sensitivity to insulin. By combining these three mechanisms in a single tablet, GLIDAPA TENMET 1000 offers comprehensive blood sugar control and helps patients manage diabetes more effectively when diet and exercise alone are not sufficient. Uses of GLIDAPA TENMET 1000 GLIDAPA TENMET 1000 is primarily used to manage high blood sugar levels in patients with Type 2 diabetes. It helps improve glycemic control and supports long-term diabetes management. Common uses include: Management of Type 2 Diabetes The medicine helps control blood glucose levels in adults with Type 2 Diabetes when lifestyle changes and single-drug therapy are not sufficient. Improving Glycemic Control The combination works through multiple mechanisms to regulate glucose levels throughout the day. Reducing Risk of Diabetes Complications Maintaining controlled blood sugar levels may help lower the risk of complications such as Heart Disease and Kidney Disease. Support for Overweight Diabetic Patients Dapagliflozin may assist in mild weight reduction, which can be beneficial for patients with diabetes. Enhancing Insulin Function Teneligliptin helps improve the body’s natural insulin response after meals. Benefits of GLIDAPA TENMET 1000 GLIDAPA TENMET 1000 offers several important benefits for patients managing Type 2 diabetes. Triple Mechanism Blood Sugar Control The combination of Dapagliflozin, Teneligliptin, and Metformin provides a comprehensive approach to controlling blood sugar levels. Improved Insulin Sensitivity Metformin helps the body respond more effectively to insulin, reducing insulin resistance. Reduction of Excess Glucose Dapagliflozin removes excess sugar through urine, helping lower blood glucose levels. Better Post-Meal Blood Sugar Control Teneligliptin helps regulate insulin release after meals, preventing sudden spikes in blood sugar. Convenient Combination Therapy Instead of taking multiple medications separately, patients can benefit from a single tablet that combines three effective antidiabetic agents. Support for Long-Term Diabetes Management Consistent use of this medication under medical supervision helps maintain stable blood sugar levels and supports overall metabolic health. Dosage The dosage of GLIDAPA TENMET 1000 should always be determined by a healthcare professional based on the patient’s medical condition, blood sugar levels, and response to treatment. General dosage guidelines include: Usually taken once daily, preferably with meals to reduce stomach discomfort. The tablet should be swallowed whole with a glass of water. Do not crush, chew, or break the extended-release tablet. Try to take the medicine at the same time each day for consistent blood sugar control. Patients should follow the doctor’s instructions carefully and should not change the dosage without medical advice. Regular blood sugar monitoring is recommended while taking this medication. Side Effects Like all medications, GLIDAPA TENMET 1000 may cause side effects in some individuals. Most side effects are mild and temporary. Common side effects may include: Nausea Diarrhea Stomach discomfort Frequent urination Headache Dizziness Mild dehydration Less common but more serious side effects may include low blood sugar (hypoglycemia), urinary tract infections, or electrolyte imbalance. Patients should seek medical attention if they experience severe symptoms such as persistent vomiting, difficulty breathing, or unusual fatigue. Precautions and Warning Before using GLIDAPA TENMET 1000, patients should inform their healthcare provider about their medical history and any medications they are currently taking. Kidney Function Monitoring Patients with kidney disease should use this medication cautiously as dapagliflozin and metformin are processed through the kidneys. Risk of Dehydration Dapagliflozin increases urination, so pa